Top compounds associated with response to KRTAP9-3


Feature Type Standardized
Nominal ANOVA
mRNA tacedinaline CTRPv2 pan-cancer AAC -0.017 0.7
mRNA quizartinib CTRPv2 pan-cancer AAC -0.016 0.7
mRNA RAF265 CTRPv2 pan-cancer AAC -0.018 0.7
mRNA Imatinib CTRPv2 pan-cancer AAC 0.016 0.7
mRNA ML258 CTRPv2 pan-cancer AAC 0.016 0.7
mRNA myricetin CTRPv2 pan-cancer AAC -0.016 0.7
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.014 0.7
mRNA Tamoxifen CTRPv2 pan-cancer AAC 0.016 0.7
mRNA GSK1059615 CTRPv2 pan-cancer AAC -0.019 0.7
mRNA BRD-K17060750 CTRPv2 pan-cancer AAC -0.016 0.7
Download CSV